# Raisecare

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/raisecare

- Industry: Biotechnology
- Headquarters: Qingdao, China
- Website: www.qdraisecare.com
- Total disclosed funding: $14M
- Latest round: Series B (Nov 3, 2023)
- Investors on record: 5

## About

Based in Qingdao, China, and founded in 2016, Raisecare is a biotech company that focuses on the field of life science and in vitro diagnostics. In 2021, the company obtained recognition from Qingdao Technology Innovation Center. In 2022, it has obtained 7 invention patents, 3 appearance patents, and 1 utility model patent. In November 2023, Raisecare raised more than CNY 100 million in series B funding led by new investor CITIC Med Fund.

The company is committed to life science research and in vitro diagnostic product development, production, sales, and services. Its products can be categorized into testing project series, fully automatic flow cytometry, fully automatic flow cytometry sample preprocessing instrument, etc.

The company will use the funds for life sciences and in vitro diagnosis.

## Funding rounds

- Series B, Nov 3, 2023, $14M — China International Capital Corporation, Jufeng S&T Venture Investment, Yanyuan Tongde Investment Fund, CITIC Med Fund
- Series A, Oct 16, 2020 — HSG

## Investors

- HSG (https://capitalatlas.ai/funds/hsg) — Series A
- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series B
- Jufeng S&T Venture Investment — Series B
- Yanyuan Tongde Investment Fund (https://capitalatlas.ai/funds/yanyuan-tongde-investment-fund) — Series B
- CITIC Med Fund (https://capitalatlas.ai/funds/citic-med-fund) — Series B